[Therapy of parkinsonism using L-dopa. I].
作者信息
Glass J
出版信息
Z Arztl Fortbild (Jena). 1972 Dec 1;66(23):1195-9.
PMID:4652156
Abstract
摘要
相似文献
1
[Therapy of parkinsonism using L-dopa. I].
Z Arztl Fortbild (Jena). 1972 Dec 1;66(23):1195-9.
2
Drug therapy of parkinsonism.
N Engl J Med. 1972 Jul 6;287(1):20-4. doi: 10.1056/NEJM197207062870105.
3
Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).α-甲基多巴肼（MK-486）对帕金森病左旋多巴治疗的改良作用
Trans Am Neurol Assoc. 1971;96:55-8.
4
[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
Wien Med Wochenschr. 1972 Jun 17;122(25):369-71.
5
[Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism].[脱羧酶抑制剂与左旋多巴联合使用。帕金森病的一种新治疗原则]
Tidsskr Nor Laegeforen. 1973 Oct 10;93(28):2113-5.
6
[Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Harefuah. 1972 Nov 1;83(9):362-4.
7
[Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].锥体外系疾病和原发性肌病患者血清及脑脊液中的铁、转铁蛋白、铜和铜蓝蛋白。基础状态下及多巴胺能药物（左旋多巴、左旋多巴+RO 4-4602、金刚烷胺）治疗帕金森病后的研究
Acta Neurol (Napoli). 1973 Jan-Feb;28(1):1-34.
8
[Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].[金刚烷胺在左旋多巴治疗帕金森病患者过程中对短暂性运动功能减退的治疗作用]
Minerva Med. 1971 Oct 31;62(82):4007-8.
9
10
L-dopa and amantadine for Parkinsonism.左旋多巴和金刚烷胺治疗帕金森病。
Drug Ther Bull. 1970 Aug 14;8(17):65-7.
Zotero 插件